On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.
A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to provide pain relief to the full extent. This is shown by the largest survey ...
Dalhousie’s Dr. Christine Chambers and her colleagues at Solutions for Kids in Pain (SKIP) are working with hospitals to ...
New technologies and care plans aim to enhance treatment options for patients in Mitchell and the surrounding area ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
healthday on MSN2d
Guidelines Developed to Address Infections Tied to Regional AnesthesiaIn multidisciplinary guidelines issued by the American Society of Regional Anesthesia and Pain Medicine and publishe ...
InsideHook on MSN1d
New FDA Approval Could Transform Pain ManagementIt’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...
From unexpected gender disparities to alarming teen statistics, discover essential facts about opioid medications that every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback